Dasatinib and Heparin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dasatinib (dasatinib) and Heparin (heparin sodium). Common drug interactions include procalcitonin increased among females and anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Dasatinib and Heparin. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.
What is Dasatinib?
Dasatinib has active ingredients of dasatinib. eHealthMe is studying from 9,407 Dasatinib users. Check the latest studies of Dasatinib.
What is Heparin?
Heparin has active ingredients of heparin sodium. It is often used in blood clots. eHealthMe is studying from 92,141 Heparin users. Check the latest studies of Heparin.
37 people who take Dasatinib and Heparin together, and have interactions are studied.

What are the common drug interactions of Dasatinib and Heparin, by gender? *:
female:
- Procalcitonin increased
- Respiratory rate increased (excess breathing rate/min)
- Septic shock (shock due to blood infection)
- Stomatitis (inflammation of mucous membrane of mouth)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
- Vascular neoplasm (tumour of vascular origin)
- Venous thrombosis limb (blood clot that forms in a vein in the limb)
- White blood cell count decreased
- Bacteraemia (presence of bacteria in the blood)
male:
- Anaemia (lack of blood)
- Hypokalaemia (low potassium)
- Haematotoxicity (toxins that destroy red blood cells)
- Malignant neoplasm progression (cancer tumour came back)
- Pneumonia
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Acute respiratory failure
- Adenovirus test positive
- Blast crisis in myelogenous leukaemia
What are the common drug interactions of Dasatinib and Heparin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Platelet count decreased
- Viral upper respiratory tract infection
- Anaemia (lack of blood)
- Hypokalaemia (low potassium)
- Leukopenia (less number of white blood cells in blood)
- Neutropenia (an abnormally low number of neutrophils)
- Thrombocytopenia (decrease of platelets in blood)
- Febrile neutropenia (fever with reduced white blood cells)
- Chills (felling of cold)
- Haematotoxicity (toxins that destroy red blood cells)
10-19:
- Bacteraemia (presence of bacteria in the blood)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Generalised oedema (swelling all over the body)
- Large intestinal ulcer
- Cardiac arrest
- Colitis (inflammation of colon)
- Left ventricular dysfunction
- Fungal sepsis (whole body infection by fungus)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Fungaemia (fungi circulate in the blood)
20-29:
- Abdominal pain upper
- Asthenia (weakness)
- Headache (pain in head)
- Superior sagittal sinus thrombosis (blood clot in the dural venous sinuses, which drain blood from the brain)
- Hypoaesthesia (reduced sense of touch or sensation)
- Refractory cancer (cancer that has not responded to treatment)
- Diarrhoea
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
- Haemorrhage (bleeding)
30-39:
n/a
40-49:
n/a
50-59:
- Pneumonia
- Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
- Asthenia (weakness)
- Blast crisis in myelogenous leukaemia
- C-reactive protein increased
- Cardiac disorder
- Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
- Diarrhoea
- Dizziness
- Drug resistance (reduction in effectiveness of a drug)
60+:
- Hypoxia (low oxygen in tissues)
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Thrombocytopenia (decrease of platelets in blood)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Lymphocytic leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes)
- Acute lymphocytic leukaemia (cancer of the white blood cells)
- Acute respiratory failure
- Cardiac failure congestive
- Fluid overload (too much fluid in the blood)
What are the existing conditions these people have? *
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 20 people, 54.05%
- Mesothelioma Malignant (cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 4 people, 10.81%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 10.81%
- Secretion Discharge: 3 people, 8.11%
- Respiratory Distress (difficulty in breathing): 3 people, 8.11%
- Pleural Effusion (water on the lungs): 3 people, 8.11%
- Pain: 3 people, 8.11%
- Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 3 people, 8.11%
- Dyspnea (difficult or laboured breathing): 3 people, 8.11%
- Agitation (state of anxiety or nervous excitement): 3 people, 8.11%
* Approximation only. Some reports may have incomplete information.
Do you take Dasatinib and Heparin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Dasatinib and Heparin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dasatinib:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Heparin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dasatinib and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Heparin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dasatinib and heparin sodium (the active ingredients of Dasatinib and Heparin, respectively), and Dasatinib and Heparin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Green Tea and Cozaar - 24 seconds ago
- Could Tracleer cause Biopsy Liver Abnormal? - 24 seconds ago
- Could Acetaminophen And Hydrocodone Bitartrate cause Road Traffic Accident? - 41 seconds ago
- Could Topotecan cause Appetite Decreased? - 42 seconds ago
- Could Topotecan cause Appetite - Decreased? - 43 seconds ago
- Drug interactions of Acetylsalicylic Acid and Urocit-K - 46 seconds ago
- Drug interactions of Acetylcysteine and Cefazolin - a minute ago
- Could Peg-Intron cause Eye Pain? - a minute ago
- Restoril vs. Lorazepam, side effect and effectiveness comparison - a minute ago
- Could Zoloft cause Exposed Bone In Jaw? - a minute ago